Metabolic Dysfunction-Associated Steatotic Liver Disease Prevalence, research insights and the future directions

This book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition.

.- Chapter 1 Introduction of MAFLD/MASLD.

.- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC.

.- Chapter 3 Decoding MAFLD’s pathophysiology.

.- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage.

.- Chapter 5 Diagnostic Advances in MAFLD/MASLD.

.- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes.

.- Chapter 7 MAFLD as a multisystemic disease.

.- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship.

.- Chapter 9 Current Standards in Therapeutic Management.

.- Chapter 10 REVOLUTIONARY BREAKTHROUGHS.

.- Chapter 11 Integrative Approaches to MAFLD/MASLD Management.

.- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS.

.- Chapter 13 Looking ahead.

.- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION.

Nahum Mendez-Sanchez is a Professor at the Department of Medicine, National Autonomous University of Mexico, Mexico City, Mexico. Xingshun Qi is a Professor at the Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, Liaoning, China.